Giampiero Girolomoni

Giampiero Girolomoni's AcademicInfluence.com Rankings

Medical

#1563

World Rank

#1915

Historical Rank

Dermatology

#22

World Rank

#32

Historical Rank

medical Degrees

Giampiero Girolomoni

Philosophy

#4811

World Rank

#7462

Historical Rank

Logic

#2190

World Rank

#3125

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Giampiero Girolomoni's Degrees

PhD Dermatology University of Padua
Doctorate Medicine University of Padua

Why Is Giampiero Girolomoni Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giampiero Girolomoni's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris (2009) (668)
Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study (2007) (647)
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. (2010) (642)
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions1 (2001) (621)
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I (2018) (589)
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II (2018) (459)
Epidemiology of atopic dermatitis in adults: Results from an international survey (2018) (456)
Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. (2014) (441)
The epidermal growth factor receptor system in skin repair and inflammation. (2008) (383)
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) (2015) (359)
IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α (1999) (331)
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. (2001) (325)
Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. (2000) (312)
Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment (2009) (312)
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. (2001) (306)
Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case–control study (2007) (292)
Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo (2001) (272)
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. (2008) (267)
Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. (2003) (264)
Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. (2000) (252)
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. (2009) (248)
Extracellular ATP Induces a Distorted Maturation of Dendritic Cells and Inhibits Their Capacity to Initiate Th1 Responses1 (2001) (244)
Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity1 (2001) (244)
Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. (2003) (234)
CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation (2006) (231)
Alerting and tuning the immune response by extracellular nucleotides (2003) (226)
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis (2018) (220)
IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. (1999) (203)
Mechanisms of immune-mediated skin diseases: an overview. (2006) (202)
Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. (1997) (202)
Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. (2005) (198)
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release (2000) (189)
Prevalence of symptoms experienced by patients with different clinical types of psoriasis (2004) (187)
Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. (1998) (186)
Human CD25+ Regulatory T Cells Maintain Immune Tolerance to Nickel in Healthy, Nonallergic Individuals 1 (2003) (186)
Mechanism of HBD-3 deficiency in atopic dermatitis. (2006) (183)
Sphingosine 1‐phosphate induces Chemotaxis of immature dendritic cells and modulates cytokine‐release in mature human dendritic cells for emergence of Th2 immune responses (2002) (177)
Keratinocytes in inflammatory skin diseases. (2005) (177)
The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis (2017) (172)
ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation1 (2005) (169)
Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE). (2015) (168)
Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. (2007) (167)
Expression and function of histamine receptors in human monocyte-derived dendritic cells. (2002) (166)
Anti–tumour necrosis factor‐α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study (2008) (165)
Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. (2002) (160)
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis (2006) (154)
Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. (2013) (153)
Disparate Cytotoxic Activity of Nickel-Specific CD8+ and CD4+ T Cell Subsets Against Keratinocytes1 (2000) (153)
Vitamin D status in patients with chronic plaque psoriasis (2012) (145)
Dendritic cells hold promise for immunotherapy. (1997) (145)
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. (2002) (144)
Canine models of atopic dermatitis: a useful tool with untapped potential. (2009) (143)
Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study (1990) (140)
Psoriasis: rationale for targeting interleukin‐17 (2012) (138)
Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis (2017) (136)
Survival rate of antitumour necrosis factor‐α treatments for psoriasis in routine dermatological practice: a multicentre observational study (2013) (135)
Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey (2015) (135)
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment (2008) (134)
The role of chemokines in allergic contact dermatitis (2001) (133)
Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasis (2017) (132)
Psoriasis and the metabolic syndrome. (2018) (130)
Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line (1996) (130)
STAT3‐dependent effects of IL‐22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation (2011) (129)
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. (2012) (126)
Drug-induced lupus erythematosus (2008) (126)
Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo (1993) (125)
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. (2005) (124)
Effector and regulatory T cells in allergic contact dermatitis. (2001) (123)
Impaired IFN-γ-Dependent Inflammatory Responses in Human Keratinocytes Overexpressing the Suppressor of Cytokine Signaling 11 (2002) (122)
Establishment of a cell line with features of early dendritic cell precursors from fetal mouse skin (1995) (119)
A cytokine‐to‐chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases (2001) (118)
Chronic Plaque Psoriasis Is Associated with Increased Arterial Stiffness (2008) (117)
European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment (2017) (112)
The contribution of keratinocytes to the pathogenesis of atopic dermatitis. (2006) (111)
IL-4 Enhances Keratinocyte Expression of CXCR3 Agonistic Chemokines1 (2000) (111)
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24‐week, randomized, controlled, investigator‐blinded pilot trial (2008) (109)
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement (2018) (109)
Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern (2012) (108)
H1 histamine receptor mediates inflammatory responses in human keratinocytes. (2004) (107)
The Influence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells (2002) (104)
Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. (2009) (102)
Drug-induced morphea: report of a case induced by balicatib and review of the literature. (2008) (102)
Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. (2011) (102)
Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management (2012) (101)
Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical update (2020) (98)
Quantitative Differences in Chemokine Receptor Engagement Generate Diversity in Integrin-Dependent Lymphocyte Adhesion1 (2002) (97)
Preliminary Evidence That Subclinical Enthesopathy May Predict Psoriatic Arthritis in Patients with Psoriasis (2011) (96)
Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture. (1990) (94)
Phenotypes of atopic dermatitis (2011) (91)
Interleukin-11 induces Th2 polarization of human CD4(+) T cells. (2001) (90)
Mid-dermal elastolysis: a clinical, histologic, and immunohistochemical study of 11 patients. (2003) (90)
Interferon-γ-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules (1998) (90)
Skin reactivity to neuropeptides in atopic dermatitis (1989) (89)
T-cell subpopulations in the development of atopic and contact allergy. (2001) (89)
Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities (2015) (89)
Treatment Approaches to Moderate to Severe Psoriasis (2017) (88)
Randomized controlled trial comparing the effectiveness of 308‐nm excimer laser alone or in combination with topical hydrocortisone 17‐butyrate cream in the treatment of vitiligo of the face and neck (2008) (88)
Vasculitis as an adverse event following immunization - Systematic literature review. (2016) (85)
Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis (2010) (84)
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry (2013) (83)
Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. (2010) (83)
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. (2010) (81)
Regulatory Effect of IFN-κ, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System (2002) (81)
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper. (2014) (80)
The epidemiology of atopic dermatitis in Italian schoolchildren (2003) (79)
Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils (2015) (79)
Capsaicin-sensitive primary sensory neurons are potent modulators of murine delayed-type hypersensitivity reactions. (1990) (78)
Biologic therapies in psoriasis: a new therapeutic approach. (2007) (78)
Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients (2013) (77)
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients (2018) (76)
The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. (2009) (75)
Prolactin stimulates proliferation of cultured human keratinocytes. (1993) (75)
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group (2019) (74)
Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. (1999) (74)
The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases (2014) (74)
Folic acid in general medicine and dermatology (2007) (73)
Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis (2000) (73)
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. (2004) (71)
EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. (2010) (71)
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study (2013) (71)
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab (2013) (70)
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis (2019) (70)
Incidence of Primary and Second Cancers in Renal Transplant Recipients: A Multicenter Cohort Study (2013) (70)
Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents (2012) (69)
Blocking TH17‐polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo (2008) (69)
Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part II. Systemic diseases. (2010) (67)
Psoriasis and systemic inflammation: underdiagnosed enthesopathy (2009) (67)
Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. (1994) (66)
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities (2020) (66)
Usefulness of the framingham risk score in patients with chronic psoriasis. (2010) (66)
Metabolic comorbidities and psoriasis. (2010) (63)
Adalimumab in the Treatment of Immune-Mediated Diseases (2014) (63)
Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis☆☆☆★★★ (1998) (62)
Chemokine networks in inflammatory skin diseases. (2004) (60)
Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. (2007) (58)
Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: in vitro evidence supporting a protective role of membrane ATPase. (1993) (58)
Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab (2014) (57)
Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases. (2010) (57)
Videocapillaroscopic alterations in erythematotelangiectatic rosacea. (2006) (57)
Cross-linking of membrane CD43 mediates dendritic cell maturation. (1999) (56)
Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis (2012) (55)
Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. (2002) (55)
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2 (2020) (54)
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis. (2016) (54)
European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis (2017) (54)
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment (2020) (53)
Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis (2008) (52)
Prurigo nodularis: an update on etiopathogenesis and therapy (2013) (52)
Immunoregulation of Allergic Contact Dermatitis (2004) (52)
Congenital Dermatofibrosarcoma Protuberans (1993) (51)
Pimecrolimus in dermatology: atopic dermatitis and beyond (2005) (51)
Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. (2002) (51)
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections (2020) (51)
Modulation of cytokine expression in mouse dendritic cell clones (1994) (51)
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis (2019) (51)
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes (2014) (50)
Activin A Induces Langerhans Cell Differentiation In Vitro and in Human Skin Explants (2008) (50)
Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis (2014) (49)
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper (2015) (49)
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis (2012) (49)
Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. (2003) (49)
Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. (2000) (49)
Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. (1993) (48)
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. (1994) (48)
Non‐alcoholic fatty liver disease fibrosis score in patients with psoriasis (2016) (48)
Perception of Disease and Doctor-Patient Relationship Experienced by Patients with Psoriasis (2009) (47)
Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes. (1997) (47)
Consensus Statement on the Safety Profile of Topical Calcineurin Inhibitors (2005) (47)
Pruritus as a Distinctive Feature of Type 2 Inflammation (2021) (45)
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab (2013) (45)
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. (2015) (45)
Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors (2014) (44)
Italian expert consensus for the management of actinic keratosis in immunocompetent patients (2016) (44)
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines (2021) (44)
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study (2020) (43)
Hyperuricemia in patients with chronic plaque psoriasis. (2014) (43)
Papular neutrophilic dermatosis and erythema elevatum diutinum following erythropoietin therapy in a patient with myelodysplastic syndrome. (2003) (43)
Distribution of HLA class II molecules in epidermal Langerhans cells in situ (1995) (42)
Cutaneous manifestations of Churg–Strauss syndrome: report of two cases and review of the literature (2011) (42)
A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It (2018) (42)
Localized Cutaneous Hyalohyphomycosis Caused by a Fusarium Species Infection in a Renal Transplant Patient (2003) (42)
Annular lichenoid dermatitis of youth. (2003) (42)
Bacteria and bacterial cell wall constituents induce the production of regulatory cytokines in dendritic cell clones. (1996) (42)
Advanced Glycation End Products in the Pathogenesis of Psoriasis (2017) (41)
Allergic Contact Dermatitis in Children With and Without Atopic Dermatitis (2012) (41)
House dust mite allergen exerts no direct proinflammatory effects on human keratinocytes. (2002) (41)
Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing. (1990) (41)
Psoriasis, the liver, and the gastrointestinal tract (2010) (41)
Microcirculatory modifications of psoriatic lesions during topical therapy (2009) (40)
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study (2017) (39)
Co-Localization of Susceptibility Loci for Psoriasis (PSORS4) and Atopic Dermatitis (ATOD2) on Human Chromosome 1q21 (2006) (39)
Langerhans cells and HIV infection. (1995) (38)
Antitumour necrosis factor‐α chimeric antibody (infliximab) inhibits activation of skin‐homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function (2007) (38)
Severe impairment of quality of life in Hailey-Hailey disease. (2005) (38)
Balneotherapy for chronic plaque psoriasis at Comano spa in Trentino, Italy (2008) (38)
Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. (2006) (38)
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry (2015) (37)
Nodular Perianal Herpes Simplex With Prominent Plasma Cell Infiltration (2003) (37)
Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. (1998) (37)
Pathogenetic mechanisms of atopic dermatitis. (2000) (36)
The Role of Interleukin-17A in Psoriatic Disease (2014) (36)
Association of functional gene variants in the regulatory regions of COX‐2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation (2007) (36)
Experimental metagenomics and ribosomal profiling of the human skin microbiome (2017) (36)
European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology (2016) (36)
Fractalkine ( CX 3 CL 1 ) as an amplification circuit of polarized Th 1 responses (2001) (36)
Considerations for Systemic Treatment of Psoriasis in Obese Patients (2016) (36)
Videocapillaroscopy in the Differential Diagnosis between Psoriasis and Seborrheic Dermatitis of the Scalp (2006) (36)
Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin (2003) (36)
Cutaneous manifestations of adult-onset Still’s disease: a case report and review of literature (2016) (36)
Erythrocytes deliver Tat to interferon‐γ‐treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro (2002) (35)
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy (2011) (35)
Contact allergy in chronic eczematous lip dermatitis. (2008) (35)
Subcutaneous sarcoidosis: report of two cases and review of the literature (2011) (35)
Efficacy of a Single Educative Intervention in Patients with Chronic Plaque Psoriasis (2009) (35)
Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases. (2016) (34)
CHLAMYDIA INFECTION (2001) (34)
One‐year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate‐to‐severe plaque psoriasis (2014) (34)
Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis. (2008) (34)
Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cells. (2002) (34)
Chronic Pruritus in the Absence of Specific Skin Disease (2010) (34)
Cardiometabolic comorbidities and the approach to patients with psoriasis. (2009) (33)
C-Reactive Protein and Markers for Thrombophilia in Patients with Chronic Plaque Psoriasis (2010) (33)
The role of cytokines in functional regulation and differentiation of dendritic cells. (1996) (33)
Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy (2014) (32)
Persistent unilateral orbital and eyelid oedema as a manifestation of Melkersson–Rosenthal syndrome (2005) (32)
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics (2017) (32)
Multinucleate cell angiohistiocytoma. (1992) (32)
Weight Reduction Alone May Not Be Sufficient to Maintain Disease Remission in Obese Patients with Psoriasis: A Randomized, Investigator-Blinded Study (2012) (32)
Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo. (2020) (32)
Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study (2018) (32)
The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada (2020) (31)
Sensitizing potential of triclosan and triclosan‐based skin care products in patients with chronic eczema (2008) (31)
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. (2019) (31)
Measuring psoriatic disease in clinical practice. An expert opinion position paper. (2015) (30)
The Role of Innate Immunity in Vitiligo (2010) (30)
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study (2017) (30)
Predictive model for delayed graft function based on easily available pre-renal transplant variables (2015) (30)
Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature. (2003) (30)
Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy (2020) (30)
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis. (2017) (29)
Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies (2021) (29)
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis (2021) (29)
Targeting IL-4 for the Treatment of Atopic Dermatitis (2020) (29)
The role of keratinocytes in the pathogenesis of atopic dermatitis. (1997) (29)
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study. (2019) (29)
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis (2018) (29)
Huriez syndrome: case report with a detailed analysis of skin dendritic cells (2000) (28)
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments (2020) (28)
Nomenclature and clinical phenotypes of atopic dermatitis (2021) (28)
Targeting tumor necrosis factor-alpha in the therapy of psoriasis. (2004) (27)
Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. (2002) (27)
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy (2014) (26)
Comparison of injection‐site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study (2018) (26)
Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release (2004) (26)
The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey (2020) (26)
Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. (2003) (26)
Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas. (2008) (26)
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis (2016) (25)
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations (2016) (25)
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature (2015) (25)
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies (2020) (25)
Primary cutaneous actinomycosis of the forehead (2003) (24)
A patient‐centred approach to biological treatment decision making for psoriasis: an expert consensus (2015) (24)
Heat urticaria: a revision of published cases with an update on classification and management (2016) (24)
Immunopathologic studies in pityriasis lichenoides. (1988) (24)
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study (2021) (24)
The Diagnostic and Therapeutic Challenge of Early Psoriatic Arthritis (2010) (24)
Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience (2019) (24)
Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. (2015) (24)
Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. (2014) (24)
Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis (2014) (24)
European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology (2017) (24)
Subacute Cutaneous Lupus Erythematosus Induced by Nifedipine (2003) (24)
Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. (2004) (24)
Targeting tumor necrosis factor a in the therapy of psoriasis. (2004) (24)
Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen-presenting cells. (2002) (23)
Immunohistochemistry of Cutaneous Graft‐versus‐Host Disease after Allogeneic Bone Marrow Transplantation (1991) (23)
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis. (2019) (23)
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registry (2020) (23)
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy (2014) (23)
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations (2021) (22)
Dendritic cells as natural adjuvants. (1999) (22)
Transition to ustekinumab in patients with moderate‐to‐severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT) (2014) (22)
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy (2022) (22)
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar (2017) (22)
The pharmacological management of patients with comorbid psoriasis and obesity (2019) (21)
Analysis of IFN-κ Expression in Pathologic Skin Conditions: Downregulation in Psoriasis and Atopic Dermatitis (2006) (21)
Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study. (2018) (21)
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. (2010) (21)
Glutathione S‐transferase and CYP1A1 gene polymorphisms and non‐melanoma skin cancer risk in Italian transplanted patients (2006) (21)
Adalimumab in severe plaque psoriasis of childhood: A multi‐center, retrospective real‐life study up to 52 weeks observation (2019) (21)
Retention rate of systemic drugs in patients with chronic plaque psoriasis (2013) (21)
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. (2011) (20)
Infliximab biosimilar CT‐P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry (2017) (20)
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. (2006) (20)
A kindred with familial progressive hyperpigmentation-like disorder: implication of fibroblast-derived growth factors in pigmentation. (2009) (20)
Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence (2013) (20)
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder? (2007) (20)
Keratinocytes in skin inflammation (2006) (20)
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry (2018) (19)
Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. (2015) (19)
Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspective (2017) (19)
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16‐week real‐life experience during the COVID‐19 pandemic in Italy (2021) (19)
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis. (2018) (19)
Role of MyD88 signaling in the imiquimod‐induced mouse model of psoriasis: focus on innate myeloid cells (2017) (19)
Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases. (2002) (19)
In vitro infection of human epidermal Langerhans' cells with HIV-1. (1995) (19)
Back to the future: a new topical approach for mild-to-moderate psoriasis. (2018) (19)
Human Dendritic Cells Are Superior to B Cells at Presenting a Major Histocompatibility Complex Class II-Restricted Heterologous Antigen Expressed on Recombinant Streptococcus gordonii (2000) (19)
Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. (1998) (19)
Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: results from extension phase of the SUPREME study (2019) (18)
A systematic review of treatments for pityriasis lichenoides (2019) (18)
Impact of the COVID‐19 pandemic on melanoma diagnosis (2021) (18)
Buschke–Ollendorff syndrome (2008) (18)
Pseudopelade of Brocq: an immunologically mediated disease? (1987) (18)
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice (2015) (18)
Intralymphatic Histiocytosis: A case report and review of literature. (2015) (18)
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. (2009) (18)
Extracellular ATP, P2 receptors, and inflammation (2003) (18)
Eruptive disseminated porokeratosis associated with internal malignancies: a case report. (2010) (18)
Peptidergic Neurons and Vasoactive Intestinal Peptide Modulate Experimental Delayed‐Type Hypersensitivity Reactions a (1992) (17)
Cost‐effectiveness analysis of TNF‐α blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health‐care system (2010) (17)
Phosphatidylserine enhances the ability of epidermal Langerhans cells to induce contact hypersensitivity. (1993) (17)
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules (2021) (17)
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic (2021) (17)
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis (2020) (17)
AAITO Position paper. Chronic urticaria: diagnostic workup and treatment. (2007) (17)
Pemphigus vulgaris following cobalt therapy for bronchial carcinoma. (1989) (17)
Prurigo pigmentosa in a pregnant woman (2007) (17)
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation (2012) (16)
Epidermal cytokine and neuronal peptide modulation of contact hypersensitivity reactions. (1996) (16)
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare. (2022) (16)
Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development (2019) (16)
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: results from Italy (2015) (16)
Vacuolar acidification and bafilomycin-sensitive proton translocating ATPase in human epidermal Langerhans cells. (1991) (16)
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies (2018) (16)
Fibulin Protein Expression in Mid-dermal Elastolysis and Anetoderma: A Study of 23 Cases. (2016) (16)
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. (2012) (16)
Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series (2017) (16)
Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO (2018) (15)
Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel (2015) (15)
Consensus on the management of patients with psoriatic arthritis in a dermatology setting (2018) (15)
Italian Euromelanoma Day Screening Campaign (2005–2007) and the planning of melanoma screening strategies (2012) (15)
Idiopathic CD4+ T Lymphocytopenia Associated with Disseminated Flat Warts and Alopecia Areata (2002) (15)
Treatment of psoriasis with etanercept: the typical patient profile (2016) (15)
An itchy vesiculobullous eruption in a patient with chronic lymphocytic leukaemia (2004) (15)
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients (2017) (14)
Impact of TNF-α antagonists on the quality of life in selected skin diseases. (2013) (14)
Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study (2009) (14)
Concept of Remission in Chronic Plaque Psoriasis (2015) (14)
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review (2020) (13)
Patients with Psoriasis Have a Higher Prevalence of Parental Cardiovascular Disease (2011) (13)
Clinical and diagnostic features of in situ melanoma and superficial spreading melanoma: a hospital based study (2012) (13)
Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines. (1994) (13)
Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis (2020) (13)
Keratosis lichenoides chronica: Case-based review of treatment options (2016) (13)
A cream based on Aquaphilus dolomiae extracts alleviates non-histaminergic pruritus in humans (2017) (13)
Keratosis lichenoides chronica (2000) (13)
Patient-relevant needs and treatment goals in nail psoriasis (2016) (13)
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study (2018) (12)
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis (2020) (12)
HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis (2020) (12)
Clinical features and course of cutaneous mastocytosis in 133 children (2016) (12)
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks (2020) (12)
Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: A case study (2006) (12)
Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis. (2006) (12)
European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations (2022) (12)
Optimizing a clinical guidance for diagnosis of atopic dermatitis in adults: joint recommendations of the Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), and Italian Society of Allergological, Occupational and Environmental Dermatolog (2019) (12)
Coexistence of dermatitis herpetiformis, gluten-sensitive enteropathy, and ulcerative colitis. (1994) (11)
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review (2020) (11)
Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis (2019) (11)
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21 (2020) (11)
Endometriosis of umbilical cicatrix: case report and review of the literature. (2008) (11)
Erosive pustular dermatosis of the leg: Long‐term control with topical tacrolimus (2011) (11)
Interleukin-11 induces Th 2 polarization of human CD 4 1 T cells (2001) (11)
Immunoregulation of hapten and drug induced immune reactions (2003) (11)
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease (2018) (11)
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies (2022) (11)
The facial grid analysis for filler injection: a cohort study of 300 patients. (2016) (11)
Facial basal cell carcinomas treated with hypo-fractionated radiotherapy: A retrospective analysis in 117 elderly patients. (2015) (11)
Lymphocyte Subpopulations of the Skin (2004) (11)
Monkeypox virus infection: what dermatologist needs to know? (2022) (10)
The pruritogenic role of the type 2 immune response in diseases associated with chronic itch (2021) (10)
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome (2020) (10)
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis (2017) (10)
PTCH1 gene haplotype association with basal cell carcinoma after transplantation (2010) (10)
Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis. (2016) (10)
Patients’ perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey (2017) (10)
Increased number and microtubule-associated dispersal of acidic intracellular compartments accompany differentiation of cultured human keratinocytes. (1992) (10)
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor. (2014) (10)
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis. (2022) (10)
Psoriasis and Metabolic Comorbidities: The Importance of Well-Designed Prospective Studies (2008) (10)
Public perception of dermatology and dermatologists in Italy: results from a population‐based national survey (2017) (10)
Palisaded neutrophilic granulomatous dermatitis and its associations with autoimmune diseases (2019) (9)
Integrin expression in middle ear cholesteatoma. (1994) (9)
A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain (2017) (9)
Kaposi's sarcoma with primary bone lesions in an HIV‐seronegative man (1996) (9)
Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. (2016) (9)
Health-related quality of life in psoriasis: an analysis of Psocare project patients. (2011) (9)
Attitude to treatment of patients with psoriasis attending spa center. (2012) (9)
Metastatic Crohn's disease in childhood (2016) (9)
IL‐17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review (2021) (9)
Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study (2022) (9)
Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference. (2014) (9)
Etanercept provides a more physiological approach in the treatment of psoriasis (2008) (9)
Disseminated lupus vulgaris. (2003) (9)
Identification of the keratin K9 R162W mutation in patients of Italian origin with epidermolytic palmoplantar keratoderma. (2004) (9)
Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel. (2019) (9)
Non-Melanoma Skin Cancer in Outdoor Workers: A Study on Actinic Keratosis in Italian Navy Personnel (2020) (9)
Hydroa vacciniforme persistent in a 60-year-old man. (1999) (9)
Experimental elicitation of itch: Evoking and evaluation techniques. (2015) (9)
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission (2019) (8)
Inosine stimulates chemotaxis, Ca2+‐transients and actin polymerization in immature human dendritic cells via a pertussis toxin‐sensitive mechanism independent of adenosine receptors (2004) (8)
Preheated autologous serum skin test in localized heat urticaria (2014) (8)
Epithelial cells and atopic diseases (2001) (8)
Drug survival of dupilumab compared to cyclosporin in moderate‐to‐severe atopic dermatitis patients (2020) (8)
Kyrle’s disease effectively treated with oral isotretinoin (2018) (8)
Functional intercellular adhesion molecule-3 is expressed by freshly isolated epidermal Langerhans cells and is not regulated during culture. (1995) (8)
Does p40‐targeted therapy represent a significant evolution in the management of plaque psoriasis? (2012) (8)
Skin diseases with high public health impact. Atopic dermatitis. (2007) (8)
Interferon-beta injection site reactions in patients with multiple sclerosis (2018) (8)
Effects of secukinumab on serum adipocytokines: preliminary data. (2017) (8)
Risk of lympho-haematological malignancies in patients with chronic plaque psoriasis: a systematic review with meta-analysis. (2021) (7)
Epidermal Langerhans cells after allogeneic bone marrow transplantation: depletion by chemotherapy conditioning regimen alone (1992) (7)
Fusidic acid betamethasone lipid cream (2016) (7)
Uncombable Hair Syndrome, Mental Retardation, Single Palmar Crease and Arched Palate in a Patient with Neurofibromatosis Type I (2007) (7)
Epidermal Growth Factor Receptor Ligands and Tumor Necrosis Factor‐α Coregulate Chemokine Expression in Human Keratinocytes (2002) (7)
Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C. (2008) (7)
The Skin in Systemic Autoimmune Diseases (2006) (7)
Skin rash and arthritis a simplified appraisal of less common associations (2014) (7)
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study—IL PSO (Italian landscape psoriasis) (2022) (7)
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis (2022) (7)
Psoriasin (S100A7) is increased in the serum of patients with moderate‐to‐severe psoriasis (2019) (7)
Glomerular filtration rate in patients with psoriasis treated with etanercept (2016) (7)
Epidermal growth factor and transferrin receptor expression in human embryonic and fetal epidermal cells (2004) (7)
Interleukin-17 is released by nickel-specific T cells and regulates ICAM-1 expression and chemokine production in human keratinocytes (1998) (6)
Pediatric CD8+/CD56+ mycosis fungoides with cytotoxic marker expression: A variant with indolent course (2018) (6)
Treatment of Psoriasis with Efalizumab in Patients with Hepatitis C Viral Infection: Report of Five Cases (2009) (6)
Neutrophilic figurate erythema: report of a new case in an adult and comparison between adult and paediatric cases (2016) (6)
BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression. (2007) (6)
Membrane ecto-ATPase on epidermal Langerhans cells. (1992) (6)
Lysyl oxidase‐like‐2 mutations and reduced mRNA and protein expression in mid‐dermal elastolysis (2018) (6)
Opportunistic deep cutaneous mycoses in solid organ transplant recipients. (2014) (6)
Metabolic Syndrome in Psoriasis (2010) (6)
Brodalumab in the treatment of chronic plaque psoriasis (2020) (6)
Anti–Tumor Necrosis Factor α Therapy in Psoriatic Arthritis and Psoriasis (2001) (6)
IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes. Synergistic or antagonist effects with interferon-g and tumor necrosis factor-a. (1999) (6)
Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report (2016) (6)
Gender differences in genital lichen sclerosus. (2020) (6)
Lipoatrophia semicircularis: a case report and review of the literature. (2016) (6)
Medikamenteninduzierter Lupus erythematodes unter besonderer Berücksichtigung von Hautmanifestationen und Anti‐TNFα‐Therapeutika (2012) (6)
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: 52-week results of the ESTEEM 2 Trial (2015) (6)
Coma Blisters in Children (2013) (6)
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus (2021) (5)
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer (2021) (5)
Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience. (2019) (5)
Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis (2021) (5)
Suppressor of Cytokine Signaling‐1 Inhibits Interferon‐g‐Induced Activation of Human Keratinocytes (2002) (5)
Yellow nail syndrome associated with sleep apnoea (2005) (5)
Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2. (2011) (5)
The role of chemokines in inflammatory skin diseases. (2004) (5)
Lysyl oxidase‐like 2 promoter hypermethylation in mid‐dermal elastolysis (2016) (5)
Unmet needs in atopic dermatitis management: an expert consensus (2021) (5)
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. (2021) (5)
Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. (2009) (5)
The burden of atopic dermatitis in adults in Italy. (2020) (5)
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis (2007) (5)
Spleen dendritic cells exhibit altered morphology and increased allostimulatory capacity after short‐term culture * (1992) (5)
Increased red blood cell distribution width in patients with plaque psoriasis (2020) (5)
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement (2018) (5)
Biosimilar infliximab: an expert view. (2015) (5)
Chemokines of Human Skin (2004) (5)
Acneiform eruption induced by cetuximab. (2007) (5)
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis (2018) (5)
Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie (2017) (5)
Phänotypen der atopischen Dermatitis (2011) (5)
Combination of efalizumab and acitretin in chronic plaque psoriasis (2007) (4)
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis (2022) (4)
Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis. (2001) (4)
Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies (2012) (4)
The Patient-Reported Disease Burden In Adults With Atopic Dermatitis: A Cross-Sectional Study In Canada and Europe (2017) (4)
Subacute Cutaneous Lupus Erythematosus Induced by Nifedipine (2003) (4)
Biological agents targeting interleukin-13 for atopic dermatitis (2022) (4)
Diabetes and the Skin (2020) (4)
Impact of Alexithymia and Disease Characteristics on Work Productivity and Activity In Psoriasis Patients With Short Disease Duration: Epidepso Multicentre Study. (2015) (4)
ICAM‐1 and LFA‐1 on mouse epidermal Langerhans cells and spleen dendritic cells identify disparate requirements for activation of KLH‐specific CD4 + Th1 and Th2 clones * (1993) (4)
Nivolumab induced morphea. (2020) (4)
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients. (2019) (4)
Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der Dermatologie (2020) (4)
Consensus on the place in therapy of TNF‐α inhibitors in the treatment of patients with chronic plaque psoriasis (2020) (4)
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) (2022) (4)
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab (2020) (4)
Non-Bullous Pemphigoid: A Single-Center Retrospective Study (2021) (4)
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis (2022) (4)
[Neuropeptides and the skin: morphological, functional and physiopathological aspects]. (1989) (4)
Glomerular filtration rate in patients with moderate‐to‐severe psoriasis (2019) (4)
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning. (2013) (4)
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. (2020) (4)
In vitro infection of human epidermal Langerhans cells with human immunodeficiency virus type 1. (1995) (4)
Expression and Skin Inflammation ERK 1 / 2 Regulates Epidermal Chemokine Girolomoni (2005) (4)
A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab. (2022) (4)
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real‐world multicentre Italian study (2020) (4)
Generation of mouse dendritic cell lines. (2001) (4)
Allergic contact dermatitis - Effector and regulatory mechanisms (2002) (4)
The skin as an immunologic organ. (2006) (3)
Quality of life in patients with plaque psoriasis treated with biologic therapies (2013) (3)
Late granuloma formation secondary to hyaluronic acid injection. (2020) (3)
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study (2022) (3)
Real World SB4 (Etanercept Biosimilar) Use in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2020) (3)
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease (2022) (3)
Is risankizumab as needed administration a good option for patients with plaque psoriasis? (2022) (3)
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial (2021) (3)
The safety profile of topical pimecrolimus in the treatment of atopic dermatitis (2005) (3)
Public perception of dermatology and dermatologists: a very relevant but untapped issue (2017) (3)
Focus on psoriatic arthritis and comorbidities (2008) (3)
Relapse of psoriatic arthritis in patients with active psoriasis switched from tumour necrosis factor‐α to interleukin‐17A inhibitor (2019) (3)
Incidence and Clinical Predictors of a Subsequent Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients With a First Nonmelanoma Skin Cancer (2017) (3)
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature (2021) (3)
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study (2021) (3)
UNILATERAL LOCALIZED HYPERHIDROSIS WITH IMMUNOHISTOCHEMICAL EVIDENCE OF VIPERGIC DYSREGULATION (1995) (3)
Current evidence on the use of the adalimumab biosimilar SB5 (ImraldiTM): a multidisciplinary perspective (2021) (3)
Undertreatment in adult patients with moderate‐to‐severe atopic dermatitis and other chronic inflammatory skin diseases (2020) (3)
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis (2021) (3)
Immune/Inflammatory Aspects (2010) (3)
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis (2020) (3)
This information is current as Nonallergic Individuals Immune Tolerance to Nickel in Healthy , Regulatory T Cells Maintain + Human CD 25 Sebastiani , (2003) (3)
Activation of immature dendritic cells via membrane sialophorin (CD43). (1997) (3)
Recombinant GM-CSF induces cytokine production in mouse dendritic cell clones. (1995) (3)
A case of kerion celsi caused by Trichophyton tonsurans (2020) (3)
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series (2019) (3)
Upadacitinib in patients with resistant atopic dermatitis: a retrospective case‐series (2022) (3)
Contact allergy in children with and without atopic dermatitis: An Italian multicentre study (2022) (3)
Keratinocytes in Atopic Eczema (2006) (3)
Flare management in atopic dermatitis: from definition to treatment (2022) (3)
Vesiculobullous drug eruptions in children. (1993) (3)
Tongue flap to treat a severe case of Miescher's cheilitis granulomatosa. (2013) (2)
AB0821 Baseline Characteristics of Patients with Moderate to Severe Psoriatic Arthritis: Post-Hoc Analysis of Responders vs Non-Responders to Etanercept (2015) (2)
Pseudoepitheliomatous, keratotic, and micaceous balanitis mimicking lichen sclerosus et atrophicus. (2020) (2)
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis (2022) (2)
Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and phase III trials (2022) (2)
Assessing patients’ characteristics and treatment patterns among children with atopic dermatitis (2021) (2)
Adrenergic urticaria successfully treated with omalizumab (2021) (2)
Deficient HBD-3 in the Skin of Atopic Dermatitis (AD) Patients Increases Susceptibility to Recurrent Viral Skin Infections (2006) (2)
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end‐products (2021) (2)
Dupilumab for recalcitrant Kimura disease (2022) (2)
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis (2022) (2)
Analysis of the 3′UTR of the prostaglandin synthetase‐2 (PTGS‐2 / COX‐2) gene in non‐melanoma skin cancer after organ transplantation (2011) (2)
Effects of apremilast on pruritus in patients with moderate to severe plaque psoriasis : results from the ESTEEM 1 and 2 trials (2015) (2)
Replica to K. Takeda et al. Commentary to Pastore et al. (2014): Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors (2014) (2)
PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids (2011) (2)
Gene expression profile in keratinocytes from atopic dermatitis patients (2005) (2)
Pigmented Papules and Patches of the Folds: A Case Series of Lcihen Planus Pigmentosus Inversus with Review of the Literature (2016) (2)
Phosphatidylserine induces augmentation of contact hypersensitivity reactions in mice (1992) (2)
[European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology]. (2020) (2)
Dendritic Cells (T‐lymphocyte Stimulating) (2001) (2)
Classifying immunopathological responses in chronic inflammatory skin diseases (2018) (2)
Tailored biological treatment for patients with moderate-to-severe psoriasis (2022) (2)
Acantholytic dyskeratotic acanthoma in an immunosuppressed patient: a case report with review of the literature (2013) (2)
Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines. (2016) (2)
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis (2022) (2)
Wells syndrome in childhood: two case reports with review of the literature (2014) (2)
The multifaceted association between psoriasis and obesity (2019) (2)
Limited induction of CD1b expression by BCG in human adherent mononuclear cells is mediated by GM-CSF (2000) (2)
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis (2021) (2)
Detection Of Hiv-1 Rna In Epidermal Langerhans Cells Of Hiv-1 Infected Patients (1993) (2)
Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs” (2015) (1)
Immunologic aspects of atopic dermatitis (1997) (1)
Pharmacological treatment of moderate-severe psoriasis in patients with cardio-metabolic comorbidities (2014) (1)
Functional expression of ICAM-3 on human epidermal Langerhans cells. (1995) (1)
Immortal mouse dendritic cell lines : new models to investigate the immunobiology of dendritic cells (1995) (1)
The Combination of Dupilumab with Other Monoclonal Antibodies (2022) (1)
Amicrobial Pustulosis of the Folds: Report of Three New Cases (2020) (1)
Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs” (2015) (1)
Dendritic Cells Regulated by Nucleotides and Nucleosides (2006) (1)
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis (2022) (1)
Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study. (2015) (1)
Multidisciplinary management of type 2 inflammatory diseases (2022) (1)
Insight into genetics of atopic dermatitis: future approaches and directions. (2003) (1)
Exfoliative cheilitis as a manifestation of factitial cheilitis in a young man. (2020) (1)
Is SARS‐CoV‐2 screening test indicated for psoriasis patients candidate to biologic therapy? (2021) (1)
Some considerations about the importance of alliance between patients and dermatologists in psoriasis (2014) (1)
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus. (2022) (1)
The expectations of patients with psoriasis during an office consultation (2013) (1)
Ultraviolet-A1 phototherapy in the treatment of primary diffuse cutaneous amyloidosis: an additional phototherapy regimen for cutaneous amyloidosis with review of treatment options (2016) (1)
Skin disease in the Medici family and the illness of Contessina de' Bardi de' Medici: a dermatological puzzle (2014) (1)
Cutaneous vasculitides and vasculopathies (2013) (1)
P479 Dupilumab improves patient-reported outcomes in atopic dermatitis patients inadequately controlled, intolerant, or inadvisable for cyclosporine-A (2017) (1)
Effects of anti-TNF-a therapy on body weight of patients with psoriasis: a retrospective control study (2008) (1)
Clinical profile and co-infections of urethritis in males (2022) (1)
In-Vitro Infection Of Epidermal Langerhans Cells With Human-Immunodeficiency-Virus Type-1 (1994) (1)
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis (2020) (1)
Corrigendum to “Measuring psoriatic disease in clinical practice. An expert opinion position paper” [Autoimmun. Rev. 14/10 (2015) p.864–874] (2016) (1)
Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches (2018) (1)
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment (2022) (1)
Biological drugs: differing mechanisms of action (2009) (1)
Keratinocytes from atopic dermatitis patients produce increased amounts of GM-CSF (1997) (1)
A case of porokeratosis with predominant follicular involvement. (2020) (1)
714 Productivity losses in adults with atopic dermatitis (AD): A cross-sectional study from clinical practices in Europe and Canada (2019) (1)
Klinische Merkmale und Behandlungen der transitorischen akantholytischen Dermatose (Morbus Grover): ein systematischer Review (2020) (1)
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management. (2020) (1)
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing (2022) (1)
Clinical profile and co-infections of urethritis in males. (2021) (1)
Chronic inflammatory skin diseases (1997) (1)
The aetiology of eyelid dermatitis in a series of 191 patients (2016) (1)
Human epidermal Langerhans cells efficiently present HIV-1 antigens to specific T cell lines. (1995) (1)
Targeting TNF-a in psoriasis and psoriatic arthritis. (2008) (1)
Role of the chemerin-ChemR23 axis in the recruitment of plasmacytoid dendritic cells in psoriatic skin (2007) (1)
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature (2021) (1)
PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema (2011) (1)
Characteristics associated with clinical response to Comano thermal spring water balneotherapy in pediatric patients with atopic dermatitis (2021) (1)
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey. (2020) (0)
Efficacy of a single educational intervention in patients with chronic plaque psoriasis (2009) (0)
Altered regulation of granulocyte/macrophage colony-stimulating factor gene expression in keratinocytes cultured from atopic dermatitis patients (1998) (0)
Integrin-Dependent Lymphocyte Adhesion Receptor Engagement Generate Diversity in Quantitative Differences in Chemokine (2002) (0)
Image Gallery: Pyoderma gangrenosum of the penis (2018) (0)
Guess what? Tufted hair folliculitis (1996) (0)
Opportunistic deep cutaneous mycoses in solid organ transplant recipients. (2014) (0)
ILDS Newsletter No. 19 (2011) (0)
Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis (2017) (0)
Contents vol. 219, 2009 (2009) (0)
Annular Erythema: New and Revisited Variants (2021) (0)
Regulatory Activity T Lymphocytes with + Function in CD4 Chemokine Receptor Expression and (2000) (0)
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy (2014) (0)
Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases (2023) (0)
Cornea Farinata and other Variants (2009) (0)
Corrigendum (2008) (0)
Reply to: Non-Bullous Pemphigoid: A Yet-to-Be Defined Disease Entity (2021) (0)
Contents Vol. 222, 2011 (2011) (0)
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis (2022) (0)
Tufted hair folliculitis (1996) (0)
Acknowledgement to Referees for Dermatology 2009 (2009) (0)
PSS3 EPIDEMIOLOGY, COSTS AND QUALITY OF LIFE IN PATIENT WITH SEVERE CHRONIC HAND ECZEMA (2010) (0)
Cultured normal human keratinocytes secret stem cell factor and express C-kit receptor (1994) (0)
Subject Index Vol. 61, 2006 (2006) (0)
Birbeck granules do not form part of the endosomal/lysosomal system in human epidermal langerhans cells in situ (1994) (0)
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis (2021) (0)
Human dendritic cells present very efficiently a heterologous antigen expressed on the surface of recombinant Gram-positive bacteria to CD4+ T lymphocites (1999) (0)
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists (2022) (0)
Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle (2021) (0)
CXCR3 Agonistic Chemokines IL-4 Enhances Keratinocyte Expression of (2013) (0)
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management (2022) (0)
Lymphoplasmacitic plaque effectively treated with imiquimod. (2019) (0)
Visual Vignette (2020) (0)
Newsletter No. 7/2009 (2009) (0)
Segregation analysis revealed hemizygotic causative mutations in a pseudoxanthoma elasticum patient (2018) (0)
PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): An Integrated Approach of Outcomes Measurement in Nail Psoriasis (2012) (0)
Predictors of subsequent primary melanoma: a case–control study (2021) (0)
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab (2023) (0)
Physiopathologie et implications cliniques de l’allergie au nickel (2004) (0)
Nodules on the Thigh after Brown Recluse Spider Venom Bite: A Quiz (2021) (0)
Idiopathic lichenoid and granulomatous dermatitis. (2020) (0)
Newsletter No. 9/2009 (2009) (0)
Skin, Rheumatism and Autoimmunity. Meeting (2006) (0)
Role of dendritic cells in cutaneous diseases (1997) (0)
Contents Vol. 61, 2006 (2006) (0)
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey (2022) (0)
Alexithymia reversion in psoriasis (2019) (0)
Iconography : Purely follicular mycosis fungoides without mucinosis: Report of two cases with review of the literature (2011) (0)
Dendritic Cell Functions Regulatory Activity of Autocrine IL-10 on (2013) (0)
GLUCAGONOMA SYNDROME. (2019) (0)
type 1 T lymphocytes migratory properties of mature cells and show a reduced capacity to attract Dendritic cells exposed to extracellular adenosine triphosphate acquire the (2013) (0)
Expression, regulation and function of B7 costimulatory molecule on human epidermal Langerhans cells. (1994) (0)
[A case of recessive dystrophic epidermolysis bullosa with a vegetative variant]. (1985) (0)
Role of neutrophils in the imiquimod (IMQ)-induced mouse model of psoriasis (2016) (0)
S005 Chronic inflammatory skin diseases (1997) (0)
Eosinophilic annular erythema successfully treated with cyclosporine. (2023) (0)
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination. (2020) (0)
Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape (2018) (0)
Faculty Opinions recommendation of Cutaneous manifestations of cystic fibrosis. (2008) (0)
Cutaneous antigen presenting cells: Langerhans cells and dermal dendritic cells (1996) (0)
Epithelial Cells: Immunological Aspects (2007) (0)
Evidence-based dermatology: research commentary. Anti-tumor necrosis factor a therapy in psoriatic arthritis and psoriasis (2001) (0)
PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis: Transit Week 52 Results (2012) (0)
Cardiometabolic comorbidities: the fingerprint of psoriasis (2013) (0)
Faculty Opinions recommendation of Reiter's syndrome: the classic triad and more. (2008) (0)
Place of apremilast in the real‐life treatment of patients with plaque psoriasis (2021) (0)
ILDS Newsletter No. 23 (2012) (0)
Faculty Opinions recommendation of Kikuchi's disease: case report and systematic review of cutaneous and histopathologic presentations. (2009) (0)
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis (2023) (0)
Preface [Hot topic: Psoriasis (Guest Editor: Giampiero Girolomoni)] (2004) (0)
Vitamin D levels in patients with psoriasis with or without arthritis (2011) (0)
The role of keratinocytes in atopic dermatitis (AD) (1998) (0)
Dendritic cells in the skin surrounding venous lower leg ulcers (1997) (0)
Randomised trial comparing excimer laser alone or in combination with topical hydrocortisone 17-butyrate in the treatment of vitiligo. (2008) (0)
Pruritus, Sleep, and Productivity: A Post Hoc Analysis of Abrocitinib Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD) From JADE MONO-2 (2021) (0)
The immune functions of epidermal langerhans cells: Edited by H. Moll, R.G. Landes Company, 1995. $89.00 (193 pages) (1996) (0)
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid (2021) (0)
Video-capillaroscopy as a diagnostic tool in psoriasis. (2005) (0)
Subsets Against Keratinocytes T Cell + and CD 4 + Nickel-Specific CD 8 Disparate Cytotoxic Activity of (2000) (0)
Supporting Vasculitis SR vaccine (2015) (0)
[Immunohistological findings in Brocq's pseudopelade: analogy with lichen planus?]. (1986) (0)
Cantú syndrome: A new case and evolution of clinical conditions during first 2‐year follow‐up (2023) (0)
Videodermoscopic follow-up: a retrospective clinical study (2015) (0)
Bleomycin-induced Flagellate Dermatitis: a Case Report (2020) (0)
Psoriasis and risk of myocardial infarction. (2007) (0)
Uncommon Non-Infectious Annular Dermatoses (2022) (0)
Pyoderma gangrenosum associated with pseudo-Pelger-Huet anomaly in a patient with idiopathic myelofibrosis. (2022) (0)
Psoriasis: impact on quality of life and comorbidities. (2006) (0)
[Nickel allergy: physiopathology and clinical implications]. (2004) (0)
A case of porokeratosis with predominant follicular involvement (2021) (0)
Dermoscopic features of nevoid melanoma: a retrospective study with systematic literature review. (2022) (0)
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study (2023) (0)
Netherton syndrome plus atopic dermatitis: Two new genetic mutations in the same patient (2021) (0)
16466 Predictors of maintenance of response in patients with moderate to severe atopic dermatitis after oral Janus kinase 1 selective inhibitor abrocitinib interruption (2020) (0)
Issue Information ‐ TOC (2016) (0)
Replica to K. Takeda et al. Commentary to Pastore et al. (2014): Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors (2014) (0)
CD43 ligation mediates dendritic cell activation (1998) (0)
Interferon-g-stimulated keratinocytes express invariant chain and HLA-DM molecule genes (1997) (0)
Commentary 2 (2005) (0)
Subject Index vol. 219, 2009 (2009) (0)
Atopic dermatitis – Immunological aspects (1999) (0)
Milia-like calcinosis cutis in Down syndrome: a new case with a review of the literature. (2021) (0)
Interstitial granulomatous dermatitis: a distinctive histological pattern with variable clinical expression. Description of five case. (2009) (0)
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. (2005) (0)
Metastatischer Morbus Crohn in der Kindheit (2016) (0)
The skin - a target structure of HIV-1 (1999) (0)
Squamous cell carcinoma arising in lupus vulgaris. (2004) (0)
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases. (2022) (0)
Italian position paper on urticaria. Italian Board on Urticaria. (2009) (0)
Nickel-Specific CD8+ and CD4+ T Cell Disparate Cytotoxic Activity of (2013) (0)
Unilateral nevoid telangiectasia syndrome of pregnancy (2014) (0)
27560 Interpreting the relationship between pruritus, sleep, and work productivity: Results from JADE MONO-2 (2021) (0)
Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy (2021) (0)
Treat Psoriasis: A New Era is Coming (2020) (0)
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin (2017) (0)
Italian position paper on urticaria (2009) (0)
Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach (2017) (0)
Advanced Glycation End Products and Psoriasis (2023) (0)
The Role of Interleukin-17A in Psoriatic Disease (2014) (0)
Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab (2013) (0)
Lymphoplasmacytic plaque effectively treated with imiquimod (2022) (0)
Distinct role for MyD88 signaling in myeloid cells and stromal cells in an imiquimod-induced mouse model of psoriasis. (2014) (0)
Sarcoma di Kaposi (2006) (0)
A dendritic cell line capable of inducing contact sensitivity reactions and sensitive to UVB radiation (1993) (0)
Impaired il-22-dependent activation of stat3 and proliferative responses in human keratinocytes overexpressing suppressor of cytokine signaling (socs)1 and socs3 (2011) (0)
Exfoliative cheilitis as a manifestation of factitial cheilitis in a young man (2021) (0)
A man with a widespread bullous eruption (2022) (0)
Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors (2014) (0)
对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明 (2018) (0)
Systemic therapy of psoriasis in diabetic patients (2015) (0)
The Treat-to-Target Project in Atopic Dermatitis: One Year On (2023) (0)
Recurrent cutaneous eosinophilic vasculitis characterized by annular purpuric lesions: A case report (2023) (0)
Coexistence of scleromyxedema and Sneddon syndrome (2021) (0)
Supporting vasculitis descriptive vaccine (2015) (0)
Red eczematous melanoma: a case report with review of the literature (2014) (0)
Job: the prototypic dermatological patient. Comments on a painting by Marcello Fogolino (2020) (0)
Idiopathic lichenoid and granulomatous dermatitis (2022) (0)
Overview of Atopic Dermatitis in Different Ethnic Groups (2023) (0)
The importance of treating mild atopic dermatitis. (2006) (0)
The "difficult patient with psoriasis", i.e. patient with moderate to severe psoriasis and metabolic comorbidities (2014) (0)
Correspondence (1986) (0)
Pathogenesis of psoriasis: genetic and environmental factors. (2006) (0)
389 Association between short-term exposure to environmental air pollution and atopic dermatitis flare under treatment with dupilumab (2023) (0)
Prevalence and cost of severe chronic hand eczema refractary to topical potent corticostreoid (2012) (0)
A case of genital primary syphilis with superimposed impetigo. (2021) (0)
Skin moisturization for xerosis related to targeted anticancer therapies. (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giampiero Girolomoni?

Giampiero Girolomoni is affiliated with the following schools:

Giampiero Girolomoni's Academic­Influence.com Rankings

Giampiero Girolomoni's Degrees

Why Is Giampiero Girolomoni Influential?

Giampiero Girolomoni's Published Works

Published Works

What Schools Are Affiliated With Giampiero Girolomoni?

Giampiero Girolomoni's AcademicInfluence.com Rankings